Abstract:Glioma is the most frequent tumor in central nervous system (CNS), constituting about 30% of CNS tumors and 80% of malignant brain tumors. The current standard strategy for glioma treatment is surgery plus adjuvant chemotherapy and concurrent radiotherapy. However, the prognosis of glioma is still poor. It has been proved that the existence of glioma stem cells and the timely repair of DNA damages are the main causes of treatment failure. Skp2 (S-phase kinase associated protein-2), a member of F-box proteins, forms the Skp2 SCF complex with Skp1, Cullin-1, and Rbx1, serves as one of the important E3-ligases in the process of ubiquitination, and is responsible for substrate recognition. Skp2 is overexpressed in a variety of human cancers and promotes cancer progression by inducing p27 degradation. Importantly, Skp2 deficiency profoundly restricts cancer progression in multiple genetic mouse tumor models. Our group has demonstrated that Skp2 is involved in the regulation of pool size and self-renewal ability of hematopoietic stem cells, as well as breast cancer stem cells and nasopharyngeal carcinoma stem cell-like cells. However, the exact role of Skp2 in the regulation of glioma stem cells and DNA damage repair in glioma has not been elucidated yet. We proposed that targeting Skp2 could promote radio- and chemotherapy sensitivity through suppressing function of glioma stem cells. We first detected the expression of SKP2 in glioma tumor tissues and found that SKP2 was highly expressed in glioma and related to the prognosis of glioma patients. We also adopted gene knockdown methods and inhibitor pretreatment with small molecules in order to suppress the level of Skp2, and then checked the sphere formation and self-renewal ability of glioma stem cell upon radio/chemo treatments. In this way we evaluated the role of Skp2 in repressing the glioma cell proliferation and subsequently triggering apoptosis. Our project will clarify the novel mechanisms about how Skp2 is involved in the glioma radio- and chemotherapy resistance, which will provide a potential target to improve the radio/chemo therapeutic effect through targeting one single target. Citation Format: Jing Wang, Hong-Kai Su, Zhong-Ping Chen, Yue Qu, Hai-Ping Cai. Investigation of targeting SKP2 to improve the treatment response in glioma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 1913.

SKA1 Promotes Malignant Phenotype and Progression of Glioma Via Multiple Signaling Pathways

Identification of Spindle and Kinetochore-Associated Family Genes As Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment

SKA1 regulates actin cytoskeleton remodelling via activating Cdc42 and influences the migration of pancreatic ductal adenocarcinoma cells

Lentivirus-Mediated Silencing of Spindle and Kinetochore-Associated Protein 1 Inhibits the Proliferation and Invasion of Neuronal Glioblastoma Cells

SKA1 Over‐expression Promotes Centriole Over‐duplication, Centrosome Amplification and Prostate Tumourigenesis

SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway

SAE1 Promotes Human Glioma Progression Through Activating AKT SUMOylation-mediated Signaling Pathways

Immunological role and prognostic value of the SKA family in pan-cancer analysis

Skp2 Modulates Proliferation, Senescence and Tumorigenesis of Glioma

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas

SKA1 promotes oncogenic properties in oral dysplasia and oral squamous cell carcinoma, and augments resistance to radiotherapy

Overexpression of SHCBP1 Promotes Migration and Invasion in Gliomas by Activating the NF‐κB Signaling Pathway

High expression of spindle and kinetochore- associated protein 1 predicts early recurrence and progression of non-muscle invasive bladder cancer.

Pancancer analysis of SKA1 mutation and its association with the diagnosis and prognosis of human cancers

SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients

Long Non-Coding RNA SPRY4-IT1 Promotes the Proliferation and Invasion of U251 Cells Through Upregulation of SKA2.

The role of SPI1/VSIG4/THBS1 on glioblastoma progression through modulation of the PI3K/AKT pathway

Abstract 1913: Investigation of Targeting SKP2 to Improve the Treatment Response in Glioma

Cmar_a_279097 509..514

Upregulation of the Long Non-Coding RNA SNHG1 Predicts Poor Prognosis, Promotes Cell Proliferation and Invasion, and Reduces Apoptosis in Glioma.

SKA1/2/3 Serves As a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma